Locate Available Clinical Trials

To view available Clinical Trial information choose from the list on the right or search using the fields below.



trial #
trial description
  • URCC 16070
  • The purpose of this study is to see if adding either prochlorperazine or olanzapine to the standard antiemetic regimen of Akynzeo and dexamethasone at chemotherapy cycle 2 can improve chemotherapy-related nausea and vomiting in people who experienced it at chemotherapy cycle 1.  We also want to find out if either of these drugs is more effective than the other in controlling chemotherapy-related nausea and vomiting.  In this study you will get the standard antiemetic regimen of Akynzeo and dexamethasone.  Additionally, you will get either prochlorperazine or olanzapine or a placebo.  Prochlorperazine and olanzapine are drugs approved by the Food and Drug Administration to be used for nausea and vomiting.  A placebo is lactose filled capsule made to look exactly like the prochlorperazine and olanzapine capsules, but has no active medication in it. 


  • WF 30917CD